MyCode: DNA sequencing for better health outcomes
With the help of our participants, we’ve been able to study a broad range of health and disease.
Through a DNA sample, we can look for genes known to increase the risk of developing certain health conditions. This helps our healthcare providers diagnose medical conditions earlier — before symptoms even appear — and find new treatments or medications to manage these diseases.
More than 275,000 people have already signed up and our goal is to give every Geisinger patient the opportunity to participate.
Step 1: Consent
Have a MyGeisinger account? Log in and complete your consent form.
Consent in person
The MyCode team can be found in Geisinger clinics and hospitals. Call the team at 844-798-1687 or email us to find a consenter near you.
Step 2: Donate your sample
Having lab work done at Geisinger? Ask the medical staff to draw an additional sample for MyCode.
Don't worry, it's at no cost to you.
Step 3: Next steps
Data is sent to the lab.
Your sample will be labeled with a unique study identification (ID) number, instead of your name or date of birth, and stored for research at our lab. Your sample may also be sent to our partners at Regeneron Genetics Center for sequencing all or part of your genome.
We are committed to keeping your data safe and secure. Information that links you to your ID number will be kept in a secure file that's protected by Geisinger.
Your DNA is analyzed for genetic changes.In a small percentage of cases — about 2 percent — we discover that a participant has a genetic change that puts them at a higher risk for one of the known genetic conditions we test for. These conditions can be medically treated or managed and include certain cancers, like breast or ovarian cancer, and heart conditions, like familial hypercholesterolemia.
If a genetic change is detected in your sample, the information will be confirmed in a certified clinical laboratory before we inform you and your healthcare provider about the finding and place the information into your medical record. At that time, we’ll provide the opportunity to speak with a member of our genetics team and/or your healthcare provider about your result.
Learn how MyCode changed these patients' lives
Geisinger's MyCode program gives Anthony hope for a cure.
Ruth Trinidad tested positive for the BRCA2 gene mutation and partnered with Geisinger to manage her care.